CAR T cell therapy (iCell Gene Therapeutics)

N/A

Report date: 2023/01/07 18:44:06

Base Information

Drug NameCAR T cell therapy (iCell Gene Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsHematologic NeoplasmsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesIcell Gene Therapeutics (Int'L) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesIcell Gene Therapeutics (Int'L) Ltd

Inactive CompaniesN/A

Active IndicationsHematologic NeoplasmsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A